What Wavelength Is Best for Red Light Therapy? A Complete Guide

What Wavelength Is Best for Red Light Therapy? A Complete Guide

The Short Answer

The most evidence-backed wavelengths for red light therapy are 630–660nm (visible red) for superficial applications and 830–850nm (near-infrared) for deeper tissue penetration. These specific wavelength ranges correspond to peaks in the absorption spectrum of cytochrome c oxidase — the primary mitochondrial photoacceptor. For most consumer wellness goals, a panel that delivers both red (~660nm) and near-infrared (~850nm) provides the most comprehensive coverage.

Table of Contents

Why Wavelength Matters

In photobiomodulation research, wavelength is one of the most critical variables. Different wavelengths of light interact with biological tissue in fundamentally different ways:

  • They penetrate tissue to different depths (longer wavelengths penetrate deeper)
  • They are absorbed by different chromophores (light-absorbing molecules) in cells
  • They trigger different downstream biological responses

This is not simply a matter of "more light = more benefit." A wavelength that perfectly targets cytochrome c oxidase will produce photobiomodulation effects; a wavelength that does not hit a relevant chromophore (regardless of intensity) will produce heat at best, and nothing useful at worst.

Photobiomodulation research has linked the biological effects of red and near-infrared light to their absorption by cytochrome c oxidase, the primary mitochondrial photoacceptor — a mechanism reviewed in detail by Hamblin (2017) (PMID: 28748217).

The Cytochrome c Oxidase Absorption Spectrum

Cytochrome c oxidase (CcO) — the enzyme at the terminus of the mitochondrial electron transport chain — is the primary photoacceptor for red and NIR photobiomodulation. CcO has four main chromophores that absorb light in the red/NIR spectrum:

  • CuA centre: absorbs at ~830nm
  • CuB centre: absorbs at ~760nm
  • Haem a: absorbs at ~600nm and ~700nm
  • Haem a3: absorbs at ~620nm and ~820nm

The composite absorption spectrum of CcO therefore shows peaks at approximately 620nm, 680nm, 760nm, and 830nm (Hamblin, 2017) (PMID: 28748217). These absorption peaks are generally considered relevant to which wavelengths device makers select for photobiomodulation panels, though clinical outcomes vary considerably by protocol, dose and condition treated — wavelength alone does not guarantee a specific clinical result.

Importantly, wavelengths outside these peaks (e.g., 700nm, 900nm) are thought to be less efficiently absorbed by CcO and may produce a smaller photobiomodulation effect per unit of light energy delivered, though head-to-head dose-response comparisons across the full spectrum are limited.

Red Wavelengths: 630–700nm

Visible red light wavelengths in the 630–700nm range are the classical photobiomodulation wavelengths with the longest research history. Key characteristics:

  • Tissue penetration: Effective to ~1–3mm depth; skin and superficial tissue
  • Primary targets: Skin fibroblasts, epidermal cells, superficial wound tissue
  • Best applications: Skin rejuvenation, collagen production, wound healing, superficial acne
  • Commonly used specific wavelengths: 630nm, 633nm, 660nm — these are the most frequently used peaks in published photobiomodulation research
Wavelength Clinical study base Key Applications
630nm Studied in clinical trials Skin rejuvenation, wound healing, collagen
633nm Studied in clinical trials Photorejuvenation, acne treatment
660nm Widely used in photobiomodulation research Most widely studied; all skin and superficial applications
670nm Some clinical studies Neurological applications; skin
680nm Some clinical studies Less studied than 660nm

A systematic review of low-level red/NIR light for aesthetic skin rejuvenation found no evidence that it needs to be avoided by people with a prior skin-cancer history, supporting a favourable safety profile for cosmetic use of these wavelengths — though this is a safety finding, not proof of efficacy for any single nanometre value (Glass, 2023) (PMID: 36722207).

Near-Infrared Wavelengths: 800–1000nm

Near-infrared wavelengths penetrate significantly deeper into tissue than visible red, making them more suitable for musculoskeletal, joint, and systemic applications. Key characteristics:

  • Tissue penetration: 5–10mm and beyond; into muscle, fat, bone and deep tissue
  • Primary targets: Muscle cells, joint tissue, deeper vasculature
  • Best applications: Athletic recovery, joint pain, deeper wound healing, systemic effects
  • Commonly used specific wavelengths: 830nm, 850nm — these fall near the CuA absorption peak and are widely used in photobiomodulation devices
Wavelength Clinical study base Key Applications
810nm Studied in clinical trials Neurological, musculoskeletal, wound
830nm Widely used in photobiomodulation research All deep tissue applications
850nm Widely used in photobiomodulation research Most widely used in consumer panels; recovery, joint health
880nm Some clinical studies Some evidence but less studied than 850nm
940nm Minimal photobiomodulation evidence Absorbed by water; primarily thermal rather than photobiomodulation

Note: Wavelengths above 900nm are increasingly absorbed by water in tissue, reducing photobiomodulation efficiency. 940nm panels produce primarily thermal effects (heat) rather than photobiomodulation — this is not inherently bad, but the mechanism and evidence base differs from classical PBM.

For musculoskeletal and pain-related outcomes, a systematic review and meta-analysis of red/NIR photobiomodulation reported reduced pain and improved function in tendinopathy (Tripodi et al., 2021) (PMID: 34391447), and a systematic review and meta-analysis found benefit for neck pain with low-level laser/light therapy, though with considerable heterogeneity between studies (Chow et al., 2009) (PMID: 19913903). A broader 2026 systematic review of photobiomodulation for chronic pain reported a generally positive but heterogeneous evidence base (Ferreira et al., 2026) (PMID: 41710353). None of these reviews isolates a single "best" NIR wavelength — results are reported across a range of protocols.

Best Wavelength by Application

Goal Best Wavelengths Reason
Skin health and rejuvenation 630–660nm (red) Superficial penetration targets skin fibroblasts
Wound healing 630–660nm and 830nm Both superficial and deeper tissue
Athletic recovery 850nm (NIR primary) Deep muscle penetration; associated with improved pain and function in musculoskeletal photobiomodulation research
Joint and bone health 830–850nm (NIR) Depth required for articular cartilage and bone; general NIR pain/function evidence, not joint-specific trials
Pain management 810–850nm (NIR) Deeper penetration; associated with reduced pain in systematic reviews of NIR photobiomodulation
Thyroid support Not established Evidence specific to thyroid application is limited and not part of our verified source base; this is not a substitute for medical evaluation of a thyroid condition
Sleep and circadian 630–660nm (red) Evening exposure without blue light disruption (general light-exposure reasoning, not a specific clinical trial finding)
General whole-body wellness 660nm + 850nm Combined superficial and deep coverage

The pain- and function-related rows above draw on the tendinopathy, neck-pain and chronic-pain reviews cited in the previous section (Tripodi et al., 2021; Chow et al., 2009; Ferreira et al., 2026). Where no verified source ties a specific wavelength to an outcome — as with thyroid support — we have removed the earlier "based on specific clinical trial protocol" claim rather than leave it unsupported.

Single vs Dual Wavelength Panels

Most quality consumer red light therapy panels now include both red (~660nm) and near-infrared (~850nm) LEDs. This dual-wavelength approach provides:

  • Superficial skin benefits from the red wavelength
  • Deep tissue benefits from the NIR wavelength
  • Combined mitochondrial stimulation at two different CcO absorption peaks

Some panels offer the ability to use red-only, NIR-only, or combined modes — which allows optimising the protocol for your specific goals (e.g., red-only for a skin session; NIR-only for a post-exercise muscle recovery session).

For guidance on selecting a quality panel with the right wavelengths: Red Light Therapy Panel Buyers Guide.

What to Ignore: Marketing Wavelength Claims

The red light therapy market has significant marketing noise around wavelengths. Common misleading claims to watch for:

  • "Our proprietary 777nm wavelength": 777nm falls in a gap between CcO absorption peaks and has very limited clinical evidence. Marketing-driven wavelength selection without evidence should raise concerns.
  • "Full spectrum infrared": "Full spectrum" in this context typically means including mid-infrared and far-infrared wavelengths that produce primarily thermal effects — not photobiomodulation. These can be useful for heat therapy but are different from PBM.
  • Extremely precise wavelength claims without spectroscopy data: Actual LED output varies. Reputable manufacturers provide independent spectroscopy verification of their LEDs' true wavelength output.
  • "Our panels use the exact NASA wavelength": NASA-funded research explored red/near-infrared LEDs, including wavelengths around 670nm, for wound-healing applications — but this does not make 670nm the "only" or "optimal" wavelength for all applications, and no single wavelength has been shown to be uniquely "the" NASA standard.

How to Evaluate a Panel's Wavelength Claims

When assessing a red light therapy panel:

  1. Check for independent spectroscopy data: Reputable manufacturers will provide or share independent third-party emission spectroscopy of their LEDs
  2. Look for 660nm and/or 850nm: These are the most commonly used wavelengths in consumer photobiomodulation devices
  3. Check irradiance claims: Wavelength without adequate power density (mW/cm²) produces no therapeutic effect; look for irradiance specifications at the treatment distance
  4. Be skeptical of "secret" or "proprietary" wavelengths: The evidence base for photobiomodulation centres on a small number of well-studied wavelength ranges; "secret" wavelengths are a marketing strategy

For more guidance: Red Light Therapy Explained: A Complete Guide | The Science of Red Light Therapy

References

  • Chow RT, Johnson MI, Lopes-Martins RA, Bjordal JM (2009). Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. The Lancet. PMID: 19913903.
  • Ferreira LMA et al. (2026). Photobiomodulation in chronic pain: a systematic review of randomized clinical trials. Frontiers in Integrative Neuroscience. PMID: 41710353.
  • Tripodi N, Feehan J, Husaric M, Sidiroglou F, Apostolopoulos V (2021). The effect of low-level red and near-infrared photobiomodulation on pain and function in tendinopathy: a systematic review and meta-analysis of randomized control trials. BMC Sports Science, Medicine and Rehabilitation. PMID: 34391447.
  • Glass GE (2023). Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation. Aesthetic Surgery Journal. PMID: 36722207.
  • Hamblin MR (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics. PMID: 28748217.

This article is for informational purposes only and does not constitute medical advice.

Back to blog